By accentuating the correlation between miRNA expression and hormone receptor expression, we emphasize the importance of exploring multi-targeted therapies in the treatment of NSCLC patients, as anti-hormonal therapy is highly accessible. The gene discussed is NR4A1; the disease is non-small cell lung carcinoma.